MEREDITH OSBORNE: Open Payments
NPI 1881244614 · MOUNT PLEASANT, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 23 payments from 9 companies in 2025. Trend: 2023 $16 · 2024 $280 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| Ascendis Pharma Endocrinology Inc | 8 | $167 |
| IBSA Pharma Inc. | 3 | $67 |
| ABBVIE INC. | 2 | $46 |
| Novo Nordisk Inc | 2 | $45 |
| Madrigal Pharmaceuticals | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $36 |
| Eisai Inc. | 1 | $32 |
| Amgen Inc. | 2 | $29 |
| Curonix LLC | 1 | $17 |
Products named: Yorvipath, Tirosint, UBRELVY, Wegovy, REZDIFFRA, XIFAXAN, Lenvima, TEPEZZA.
Industry payments across SC — which companies pay providers there.
